
SuperCom wins second Indiana monitoring contract ahead of December rollout
The county-level award bills by daily active units, but SuperCom disclosed no value, contract term or initial unit count.

Four newly disclosed wind and solar power agreements total 934 megawatts and belong to an existing US$4 billion commitment.

The county-level award bills by daily active units, but SuperCom disclosed no value, contract term or initial unit count.

The pooled Phase 2 analysis covers 43 evaluable patients, while a randomized Phase 3 survival analysis is planned for 2027.
The French treasury company issued 46,694 ordinary shares, taking its bitcoin reserve to 3,554 while expanding its equity base.
The US$99,000 cash deal would also give North Peak full ownership of Avon, with no seller royalties or shares issued.

All claims and counterclaims have been dismissed; Geneoscopy says the remaining settlement terms are confidential.

Patient sales are scheduled to begin Nov. 18, ahead of a two-day celebration, while the company reports 191 locations nationwide.

The Kaia agreement ties revenue to secured transactions, while Bitcoin Quantum targets a first-half 2027 mainnet launch.

A Korean lead banker is expected shortly, while any listing would require exchange and regulatory approvals.
Drilling is due to start by Nov. 23, but Apollo has disclosed neither a program budget nor a pre-feasibility completion date.
The partners will split development expenses and bank guarantees estimated at NIS334 million, with grid approval still required.
The Alberta Growth Connector needs commercial support and approvals; TC Energy disclosed no budget or specific in-service date.
The company reports US$10 million raised through its SATS preferred-share program, with no updated common-share count in the CEO's post.
Private consumption fell 0.3 per cent in July-September, while net exports subtracted 0.6 percentage points from quarterly growth.
Florida regulators counted 170 Trulieve locations on Nov. 6; the new store announcement gives no updated statewide total or first sales date.
Common-share sales and interest income funded the preferred buyback, while the December dividend rate stays at 12 per cent.
Gold, silver, uranium, lithium, copper and rare earths: the producers, the developers and the projects behind them.
View all
The gold-silver project would require C$604.9 million in initial capital, using US$3,550 gold and US$50 silver.
Medical and pharmaceutical developments, psychedelics, and the research and safety questions around them.
View all
REGAL recorded median survival of 24.0 months versus 14.7 months on best available treatment, with a biologics filing planned for 2027.
Technology, computing, crypto and cannabis, and the listed companies moving in them.
View all
Deliveries from Central Oregon could begin as early as 2030, while the power price, contract term and construction funding remain undisclosed.
The proposal would exchange each block of 100 common shares for US$2 cash and preferred stock with a US$24 stated value.
Uranium, lithium, oil and gas, hydrogen and the grid: the fuels and the companies behind them.
View all
A fixed 7 per cent coupon replaces the floating rate, while holders can demand repayment in 2029 or convert at an initial US$6.51 per share.

The Financial Times identifies Amazon as the customer, while Fermi says a definitive long-term lease remains under negotiation.

The explorer will reassess working capital needs and financing alternatives after dropping its October offering.
Licensed producers, retail, policy, and the psychedelics companies moving through the clinic.
View all
FTSE Russell's next list update is Nov. 20, with membership changes scheduled to take effect after the Dec. 11 market close.

The company held C$2.356 million in cash at Sept. 30 and is negotiating a non-binding proposal to acquire a controlling stake in a Polish drone business.

Trading continues on Nasdaq and the TSX as the cannabis producer faces a consecutive-day bid-price test to regain compliance.

International medical sales supplied 59 per cent of quarterly revenue, while gross margin and adjusted EBITDA declined sequentially.